FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135771259> ?p ?o ?g. }

• W2135771259 endingPage "198" @default.
• W2135771259 startingPage "190" @default.
• W2135771259 abstract "Fondaparinux has recently been approved in patients with acute coronary syndromes. The primary aim of this study was to describe the changes in use of anticoagulants between January 2006 and December 2007. The secondary aim was to compare 30-day mortality and rate of a combined end point (30-day death or major bleeding) according to the initial and final anticoagulant agent used. The rates of use of unfractionated heparin (UFH), enoxaparin, and fondaparinux were compared by periods of 1 month in a multicenter registry. The initial anticoagulant (first used at admission), the final anticoagulant (last used during hospitalization), and switches in anticoagulation were recorded. Temporal trends in monthly use of each anticoagulant were assessed; 30-day mortality rates and the combined end point were compared according to initial and final anticoagulant. Among 2,874 patients included, the first anticoagulant used was UFH in 26%, enoxaparin in 59%, and fondaparinux in 15%. Respective figures for final anticoagulant were 17%, 56%, and 27%. Although 3 centers did not use fondaparinux (community centers with catheterization laboratory), the overall rate of use of fondaparinux, as initial and final anticoagulant, increased at the expense of the use of enoxaparin. We observed a growing proportion of patients with a switch from UFH to either enoxaparin or fondaparinux, ranging from 5% at the beginning to 25% at the end of the study. Patients treated with UFH were older, had more comorbidities, were at higher risk, and received fewer guidelines-recommended treatments. In patients submitted to angioplasty and treated with fondaparinux, a bolus of 60 IU/kg of UFH was added. After adjustment, 30-day mortality and combined end point rates were higher in patients treated with UFH. Irrespective of the type of acute coronary syndromes, patients treated with enoxaparin or fondaparinux had similar outcomes. Between 2006 and 2007, the use of fondaparinux in patients with acute coronary syndromes increased considerably, either because it was used instead of enoxaparin or because of a switch from UFH. Adjusted mortality in patients treated with fondaparinux was lower than with UFH and similar to enoxaparin." @default.
• W2135771259 created "2016-06-24" @default.
• W2135771259 creator A5009035216 @default.
• W2135771259 creator A5015723823 @default.
• W2135771259 creator A5019384881 @default.
• W2135771259 creator A5019653587 @default.
• W2135771259 creator A5023572557 @default.
• W2135771259 creator A5041191656 @default.
• W2135771259 creator A5049740666 @default.
• W2135771259 creator A5089939086 @default.
• W2135771259 date "2010-02-01" @default.
• W2135771259 modified "2023-09-27" @default.
• W2135771259 title "Routine use of fondaparinux in acute coronary syndromes: A 2-year multicenter experience" @default.
• W2135771259 cites W1994506260 @default.
• W2135771259 cites W2106722961 @default.
• W2135771259 cites W2114198397 @default.
• W2135771259 cites W2117254307 @default.
• W2135771259 cites W2120569650 @default.
• W2135771259 cites W2129719013 @default.
• W2135771259 cites W2131370832 @default.
• W2135771259 cites W2134124835 @default.
• W2135771259 cites W2134246748 @default.
• W2135771259 cites W4205805944 @default.
• W2135771259 cites W70145905 @default.
• W2135771259 doi "https://doi.org/10.1016/j.ahj.2009.11.003" @default.
• W2135771259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20152216" @default.
• W2135771259 hasPublicationYear "2010" @default.
• W2135771259 type Work @default.
• W2135771259 sameAs 2135771259 @default.
• W2135771259 citedByCount "15" @default.
• W2135771259 countsByYear W21357712592012 @default.
• W2135771259 countsByYear W21357712592014 @default.
• W2135771259 countsByYear W21357712592016 @default.
• W2135771259 countsByYear W21357712592017 @default.
• W2135771259 countsByYear W21357712592019 @default.
• W2135771259 countsByYear W21357712592021 @default.
• W2135771259 countsByYear W21357712592022 @default.
• W2135771259 crossrefType "journal-article" @default.
• W2135771259 hasAuthorship W2135771259A5009035216 @default.
• W2135771259 hasAuthorship W2135771259A5015723823 @default.
• W2135771259 hasAuthorship W2135771259A5019384881 @default.
• W2135771259 hasAuthorship W2135771259A5019653587 @default.
• W2135771259 hasAuthorship W2135771259A5023572557 @default.
• W2135771259 hasAuthorship W2135771259A5041191656 @default.
• W2135771259 hasAuthorship W2135771259A5049740666 @default.
• W2135771259 hasAuthorship W2135771259A5089939086 @default.
• W2135771259 hasConcept C126322002 @default.
• W2135771259 hasConcept C141071460 @default.
• W2135771259 hasConcept C164705383 @default.
• W2135771259 hasConcept C2776877702 @default.
• W2135771259 hasConcept C2777557582 @default.
• W2135771259 hasConcept C2777565915 @default.
• W2135771259 hasConcept C2778205648 @default.
• W2135771259 hasConcept C2780400711 @default.
• W2135771259 hasConcept C2780868729 @default.
• W2135771259 hasConcept C2991741193 @default.
• W2135771259 hasConcept C42219234 @default.
• W2135771259 hasConcept C500558357 @default.
• W2135771259 hasConcept C71924100 @default.
• W2135771259 hasConceptScore W2135771259C126322002 @default.
• W2135771259 hasConceptScore W2135771259C141071460 @default.
• W2135771259 hasConceptScore W2135771259C164705383 @default.
• W2135771259 hasConceptScore W2135771259C2776877702 @default.
• W2135771259 hasConceptScore W2135771259C2777557582 @default.
• W2135771259 hasConceptScore W2135771259C2777565915 @default.
• W2135771259 hasConceptScore W2135771259C2778205648 @default.
• W2135771259 hasConceptScore W2135771259C2780400711 @default.
• W2135771259 hasConceptScore W2135771259C2780868729 @default.
• W2135771259 hasConceptScore W2135771259C2991741193 @default.
• W2135771259 hasConceptScore W2135771259C42219234 @default.
• W2135771259 hasConceptScore W2135771259C500558357 @default.
• W2135771259 hasConceptScore W2135771259C71924100 @default.
• W2135771259 hasIssue "2" @default.
• W2135771259 hasLocation W21357712591 @default.
• W2135771259 hasLocation W21357712592 @default.
• W2135771259 hasOpenAccess W2135771259 @default.
• W2135771259 hasPrimaryLocation W21357712591 @default.
• W2135771259 hasRelatedWork W1613605883 @default.
• W2135771259 hasRelatedWork W2061130726 @default.
• W2135771259 hasRelatedWork W2103247642 @default.
• W2135771259 hasRelatedWork W2112564023 @default.
• W2135771259 hasRelatedWork W2115993405 @default.
• W2135771259 hasRelatedWork W2125322011 @default.
• W2135771259 hasRelatedWork W2153904317 @default.
• W2135771259 hasRelatedWork W2344421872 @default.
• W2135771259 hasRelatedWork W3013776472 @default.
• W2135771259 hasRelatedWork W4378172224 @default.
• W2135771259 hasVolume "159" @default.
• W2135771259 isParatext "false" @default.
• W2135771259 isRetracted "false" @default.
• W2135771259 magId "2135771259" @default.
• W2135771259 workType "article" @default.